[Istanbul, Türkiye – September 2025]

The premium medical aesthetics brand ERBELLA, developed by USCarePharm, recently participated in the international aesthetics symposium “A’dan Z’ye Estetik Zirvesi” held in Türkiye, where it introduced its flagship product ERBELLA AQ to great acclaim from local dermatologists and aesthetic practitioners.

The symposium serves as a major academic exchange platform where leading Turkish dermatologists and aesthetic specialists share the latest clinical insights and procedural experiences. Over the years, it has established itself as one of the most influential events in the country’s medical aesthetics community.

Highlighting Advanced K-Aesthetic Innovation

ERBELLA’s Turkish partner, Dosa Medikal, a leading distributor of medical and aesthetic solutions in Türkiye, played a key role in representing the brand. Through its booth and live demonstrations, Dosa Medikal showcased ERBELLA’s cutting-edge technology and product value to a wide range of local physicians and specialists.

At the center of attention was ERBELLA AQ, an innovative liquid-type PLLA skin booster combining poly-L-lactic acid (PLLA) with cross-linked hyaluronic acid (HA) in a ready-to-use suspension form. Unlike conventional powder-type PLLA products, ERBELLA AQ requires no reconstitution, ensuring higher procedural convenience and stability.

Next-Generation Formulation for Natural Volume and Safety

This liquid formulation technology enhances clinical usability for practitioners while minimizing the risk of nodule formation. The product provides an instant, natural-looking volumizing effect post-procedure, while the PLLA component gradually stimulates collagen synthesis for long-lasting improvement. Meanwhile, the cross-linked HA component ensures sustained hydration and structural support.

Thanks to its stable suspension format, ERBELLA AQ significantly reduces the risk of granuloma or nodule formation, offering a distinct safety advantage over conventional fillers. At the symposium, local doctors praised its “immediate volume enhancement and natural longevity”, which drew strong attention throughout the event.

Expanding Presence in Türkiye and Beyond

By participating in the symposium, ERBELLA has strengthened its brand recognition in the Turkish market and accelerated its expansion through strategic local partnerships.
The brand aims to further establish itself globally as a next-generation aesthetic solution that achieves natural and lasting beauty through scientifically advanced bio-formulations.

“ERBELLA AQ is not just a volumizing product — it’s a solution that delivers natural, enduring beauty,” said an ERBELLA representative.
“This symposium was a meaningful opportunity to directly communicate its value to local experts in the aesthetic field.”

With Türkiye’s growing status as a global hub for beauty and aesthetics, driven by its strategic position between Europe and the Middle East and its strong beauty culture, the future market potential for ERBELLA AQ looks exceptionally promising.